Cancer Options Blog

This blog is a way of sharing, supporting and educating anyone dealing with a cancer-related illness about the options and treatments they have at their disposal.

You're browsing: Home » About


About

This Article was Written December 18th, 2007

IsoRay Medical™ was founded in Richland, Washington in 1998 to develop, manufacture and market isotopes for use in the medical treatment of various malignant diseases. Company founders included recognized experts in the medical isotope field, including Lane A. Bray, chief chemist of IsoRay Medical™, who developed the patented process for economically separating and purifying Cesium-131.

In March 2003 IsoRay Medical™ Inc. received clearance to market Cesium-131 from the Food and Drug Administration for the treatment of prostate, breast, liver, brain, head and neck cancers and other malignant disease. In October of 2004, a patient was first treated with Cesium-131 at the University of Washington Medical Center.

Beginning more than 40 years ago, Cesium-131 was the first choice over other radioactive medical isotopes, although scientific and economic considerations prevented its development. Once these hurdles were overcome, IsoRay Medical™, Inc. was formed to bring the new treatment tool to market.

The Cesium-131 Brachytherapy Seed offers physicians and their patients a new choice in isotope for the treatment of prostate cancer by combining a significantly shorter half-life with a high level of energy.

Treating prostate cancer using Cesium-131 is only the first step. The company expects to broaden treatment options with the development of protocols for the treatment of breast, liver, lung, pancreatic and other malignancies.

PLEASE post a comment below

  • Categories

  • Subscribe

    All posts by all authors Google Reader or Homepage Subscribe Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online Add to My AOL Subscribe in Rojo Add to Technorati Favorites!
    Business Blogs - BlogCatalog Blog Directory

    Enter your email address:

    Comments (RSS)

  • Random Posts & Pages

    De Niro Beats Prostate Cancer Suit

  • A Los Angeles judge on Tuesday granted the actor's request to toss a lawsuit filed against him by an insurance company that claimed De Niro intentionally withheld that he had prostate cancer before the insurer signed on to cover one of his films. Fireman's Fund Insurance Co. insured the production of
  • Are Prostate Needle Biopsies Predictive Of The Laterality Of Significant Cancer And Positive Surgical Margins?

  • Are Prostate Needle Biopsies Predictive Of The Laterality Of Significant Cancer And Positive Surgical Margins? UroToday.com - In the online edition of the British Journal of Urology International, Dr. Rodrigo Frota presents the single surgeon laparoscopic radical prostatectomy (LRP) experience of Dr. Inderbir Gill. The study is a retrospective review with the intent
  • Legal Notices

  • IsoRay Medical, Inc. Website Terms Of Use Agreement And Disclaimer Of Liability Welcome to www.isoray.com (the “Website”). IsoRay Medical, Inc. and its affiliates (“we,” “us” or “IsoRay”) provide the information and content on this Website as a convenience and for general informational and educational purposes only. By accessing this Website, you, and any parties
  • Contact

  • Lori Woods 350 Hills Street, Suite 106 Richland, WA 99354 Phone (509) 375-1202 Email: lwoods@isoray.com
  • Obese Prostate Cancer Patients Benefit From Brachytherapy

  • Brachytherapy, also called seed implants, may be a more beneficial treatment than surgery or external beam radiation therapy for overweight or obese prostate cancer patients, according to a study published in the August issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic
  • Cardiac Deaths Do Not Appear To Be Increased By Hormone Therapy For Prostate Cancer

  • Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by Massachusetts General Hospital (MGH) researchers. While a 2006 report from members of the same study team found that treatment with gonadotropin-releasing hormone
  • New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreading

  • New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreading ScienceDaily (Feb. 12, 2009) — Howard Hughes Medical Institute researchers have identified a new biological marker present in the urine of patients with prostate cancer that indicates whether the cancer is progressing and spreading. Experiments reported in the journal Nature, the scientists
  • New Web Site Helps Doctors And Prostate Cancer Patients Make Better Treatment Choices

  • ScienceDaily (Sep. 23, 2008) — Doctors have created a free online computer tool, the CaP Calculator, that provides cancer specialists access to the latest prostate cancer research and helps them better individiualize each patient's treatment options, according to a study presented in a scientific session on September, 23, 2008, at
  • All About Robot-Assisted Prostate Surgery

  • What Should You Know About FascinatingTreatment Option?By Matthew Schmitz, M.D., About.com GuideCreated: November 19, 2009About.com Health's Disease and Condition content is reviewed by the Medical Review BoardRobot-assisted prostate surgery is a relatively new treatment option for prostate cancer. So what do you need to know about this fascinating surgical option?How Does Robot-Assisted Prostate
  • Find Prostate Cancer News, Discussions and Information

  • Thank you for visiting CancerOptions.org. This site is intended to provide news and information about Prostate Cancer, as well as a forum for discussion. If you, a family member, or a friend may benefit from learning, reading and sharing experiences related to Prostate Cancer, please explore this site.


  •  

    March 2010
    M T W T F S S
    « Jan    
    1234567
    891011121314
    15161718192021
    22232425262728
    293031